Immediate impact on Indian pharma exports unlikely: Pharmexcil chairman Namit Joshi
Pharmexcil chairman Namit Joshi. File | Photo Credit: Special Arrangement India’s pharma exporters body Pharmexcil does not anticipate any immediate impact of the 100% tariff on branded and patented pharmaceutical imports the U.S. President Donald Trump annnounced on September 25 (Thursday) that left the world trade already reeling under his other recent tariff decisions in…
Read More “Immediate impact on Indian pharma exports unlikely: Pharmexcil chairman Namit Joshi ” »